Demystifying cancer screening and detectionFebruary 21, 2024Before we can broadly incorporate these tests into our clinical practice, we need to understand how they work, consider the evidence behind them.
SPONSORED CONTENTThe clear reco for hidden stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More
Puppy regrows jaw after mandibulectomyFebruary 5, 2024Tyson, a three-month-old French bulldog, had its lower left mandible removed at the Cornell University College of Veterinary Medicine due to a malignant oral tumor
VPN Plus+ ExclusiveRecent Advancements in OncologyJanuary 31, 2024In this session: Craig Clifford, DVM, MS, DACVIM (Oncology), describes the latest in the field of oncology, including a chemotherapy sensitivity assay from Imprimed to help guide drug decisions, a new conditionally approved drug for canine lymphoma called Laverdia CA-1, and the use of the oncoK9 liquid biopsy test from PetDx.
Precision medicine aim of new AI-driven projectNovember 27, 2023The AI-driven digital imaging platform will be developed to collect, collate, and analyze patient data from the UF College of Veterinary Medicine’s clinical caseload across animal species.
Chinese herbs for cancer: Facts, folklore, and fabrications surround their useNovember 24, 2023"Some Asian herbs act as chemosensitizers and radiosensitizers; others are chemoprotective and radioprotective. How all these herbs and drugs interact when co-administered remains anybody’s guess."
Limb-sparing treatment for canine osteosarcoma to be explored in new studyNovember 14, 2023The new research is set to evaluate the effectiveness of a novel drug combination tailored to giant-breed dogs diagnosed with osteosarcoma.
AI aids in precision treatment for cancerSeptember 28, 2023This year, approximately six million dogs will be diagnosed with cancer. Although the incidence of canine cancer is nearly three times higher than human cancer, veterinarians have far fewer tools at their disposal to effectively treat their patients.
Controlling tumor growth target of cancer trialAugust 18, 2023 Improving outcomes for dogs afflicted with a particularly aggressive and fatal type of cancer is the goal of a clinical trial currently underway. A newly funded study will evaluate the potential of a cancer drug to control tumor growth for dogs with histiocytic sarcoma. The multi-center clinical trial, which is being conducted at Michigan State University (MSU), University of Florida, University of Wisconsin, and Virginia Tech, will be funded by the Bernese Mountain Dog Club of America (BMDCA) through Morris Animal Foundation's Donor-Inspired Study program. Histiocytic sarcoma was first described in Bernese mountain dogs in the late 1970s, but has since been noted in many other breeds, Morris Animal Foundation reports. "Histiocytic sarcoma is a devastating disease, and traditional chemotherapeutic drugs have shown limited success in improving treatment outcomes, especially with the disseminated form of the disease," says the study's principal investigator, Vilma Yuzbasiyan-Gurkan, PhD, a professor of microbiology, molecular genetics, and small animal clinical sciences at MSU. "Based on our studies of the molecular pathways driving tumor growth, we now have an opportunity to use a targeted approach in …
Canine cancer study reveals alarming hemangiosarcoma prevalenceAugust 1, 2023Morris Animal Foundation’s Golden Retriever Lifetime Study has now reached a milestone with the accrual of 500 cumulative diagnoses of four major cancers in dogs: hemangiosarcoma, lymphoma, high-grade mast cell tumor, and osteosarcoma.
Using liquid biopsy for cancer detectionJuly 28, 2023Technology in the form of liquid biopsy is helping us move the needle on early cancer detection in dogs.
